BioSpace News Archive

The Centers for Disease Control reports that in the United States, more people are addicted to nicotine than to any other drug and that nicotine may be as addictive as heroin, cocaine, or alcohol. Research from the World Health Organization shows that more than 7 million people die every year from tobacco use, including nearly 900,00 from second-hand smoke.

People who use illicitly-made street opioids and test them for fentanyl by using fentanyl test strips (FTS) are five times more likely to engage in safer drug use behaviors when the test comes back positive, according to a new study by RTI International, a leading non-profit research institute, published today in the International Journal of Drug Policy.

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved NUZYRA™ (omadacycline) for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI).

Turnbridge, one of the nation’s leading addiction treatment programs, announces the expansion of its services to treat eating disorders.

NewMed Ltd., based in Kent, has teamed up with a number of complimentary and alternative healthcare experts following the launch of their new division, which offers PEMF therapy for professionals. Their latest range of practioner-ready devices offers PEMF therapy at much higher intensities for stimulating cellular repair to improve your body’s overall performance, including improving recovery time, pain-relief and sleep

Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis, today announced the issuance of a Priority Health of Michigan Medical Policy.

With stress levels at an all-time high, Vital Scout helps consumers understand and manage the impact of stress from daily routines

BlueRock Therapeutics, LP announced today that Dr. Emile Nuwaysir, the Company’s President and Chief Executive Officer, has been elected Vice Chairman of the Alliance for Regenerative Medicine (ARM), an international organization representing the cell and gene therapies community.

Audentes Therapeutics, Inc. today announced that Co-Founder and Chief Executive Officer (CEO) Matthew R. Patterson has been appointed Chairman of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and broader regenerative medicine sector. Mr. Patterson has served as Vice Chairman of ARM since August 2016.

Rebiotix Inc and Baylor College of Medicine and Texas’s Children’s Hospital announce a collaboration that has resulted in a novel analytical approach to assessing patient microbiomes that can differentiate between a dysbiotic, or “unhealthy,” and restored state.